Skip to main content
# Title Department Research Year
51 Computational Design of Azine-Linked Hybrids of 2-Indolinone-Thiazolodine Scaffold as Novel and Promising Quorum Sensing Inhibitors Department of Medicinal Chemistry 2024
52 Intranasal delivery of sulpiride nanostructured lipid carrier to central nervous system; in vitro characterization and in vivo study Department of Industrial Pharmacy 2024
53 Selective fluoride detection based on modulation of red emissive carbon dots fluorescence by zirconium-alizarin complex: Application to Nile River water and human saliva samples Department of Pharmaceutical Analytical Chemistry 2024
54 Spectral, XRD, morphological, DFT, and molecular modeling investigations of newly prepared isatin Schiff base complexes Department of Medicinal Chemistry 2024
55 Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma Department of Medicinal Chemistry 2024
56 Carbon Nano-Dots based potentiometric sensor for the assay of the antiviral agent; Valacyclovir: In-Depth DFT Calculations, application to the pharmaceutical formulation and greenness assessment Department of Medicinal Chemistry 2024
57 Synthesis new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
58 A sustainable HPTLC approach for green assessment of Tyrosine to phenylalanine ratio in chronic kidney disease Department of Pharmaceutical Analytical Chemistry 2024
59 A green chemistry approach for preparation of metronidazole-zinc (ІІ) complexes: In vitro characterization, antimicrobial activity and promising cytotoxicity Department of Pharmaceutics 2024
60 New series of 4, 6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024